In this message, Dr. Gordon discusses the role of NIMH and others in the bench-to-bedside story of bexanolone, which has just been approved by the FDA as the first treatment specifically for postpartum depression.
from NIMH News Feed https://ift.tt/2FeKjj1
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment